Holen Sie sich die Stockscreener-App
1.89
0.53%
-0.01
Schlusskurs vom Vortag:
$1.90
Offen:
$2.065
24-Stunden-Volumen:
1.70M
Relative Volume:
2.71
Marktkapitalisierung:
$240.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-57.09M
KGV:
-4.1842
EPS:
-0.4517
Netto-Cashflow:
$-51.43M
1W Leistung:
+9.25%
1M Leistung:
-16.37%
6M Leistung:
-8.25%
1J Leistung:
+151.33%
1-Tages-Spanne:
$1.87
$2.065
1-Wochen-Bereich:
$1.65
$2.065
52-Wochen-Spanne:
$0.62
$4.3101
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
1.89 | 240.18M | 0 | -57.09M | -51.43M | -0.4517 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
Nautilus Biotechnology And 2 Promising Penny Stocks To Consider - Sahm
Nautilus Biotechnology to present single molecule proteomics webinar on Voyager Platform - Traders Union
Nautilus Biotechnology to announce Q2 2026 results on July 28 - scanx.trade
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 - Investing News Network
Nautilus Biotechnology sets July 28 call on Q2 results - Stock Titan
Enterprise value to EBIT forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to book forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to sales forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology event to reveal new Iterative Mapping method for scientific clarity - Traders Union
Form 13D/A Nautilus Biotechnology For: 30 June By Investing.com - Investing.com Nigeria
Andreessen Horowitz trims Nautilus (NAUT) stake in June 2026 block trade - Stock Titan
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Value Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Microcap Value Benchmark Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 3000E Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell Microcap Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Value Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 3000E Value Benchmark - marketscreener.com
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nautilus Biotechnolgy, Inc. Actuals & Estimates (NASDAQ:NAUT) - TradingView
NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Chart - ChartMill
NAUT Forecast — Price Target — Prediction for 2027 - TradingView
Press Release: Nautilus Biotechnology Reports First Quarter 2026 Financial Results - Moomoo
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Director at Nautilus (NAUT) granted 45,000 stock options vesting monthly - Stock Titan
Nautilus Biotechnology (NAUT) grants 45,000 stock options to director - Stock Titan
NAUTNautilus Biotechnology Inc Earnings - Finviz
Nautilus Biotech stockholders approve directors and governance items - TipRanks
Nautilus Biotechnology (NAUT) investors approve directors, auditor and annual Say on Pay - Stock Titan
NAUT News | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT) - ChartMill
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nautilus Biotechnology Inc (NAUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nautilus Biotechnology Inc (NAUT) Institutional Confidence - TradingKey
Nautilus Biotechnology Inc (NAUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nautilus Biotechnology Inc (NAUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nautilus Biotechnology Inc (NAUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nautilus Biotechnology (NAUT) Slides 2.67% as Shares Test Key Support ZoneETF AUM Growth - newsline.com
Nautilus Biotechnology (NAUT) Holds Near Support After Modest UptickETF Outflow Streak - newsline.com
Nautilus Biotechnology (NAUT) Shows Modest Gains Amid Tight Trading RangeNaked POC - newsline.com
Nautilus Biotechnology (NAUT) Edges Higher Amid Biotech Sector Gains; Resistance Test in FocusForce Index - newsline.com
Nautilus Biotechnology (NAUT) Plunges 10.8% as Bearish Momentum BuildsLow Risk Entry Stocks - newsline.com
Nautilus Biotechnology2026 Funding Rounds & List of Investors - Tracxn
Tau proteoform quantification research unveiled by Nautilus Biotechnology at ASMS2026 - Traders Union
Andreessen Horowitz (NAUT) funds sell 5M shares, retain near-10% stake - Stock Titan
Andreessen Horowitz funds trim Nautilus (NAUT) stake with 5M-share open-market sale - Stock Titan
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):